NCT02253212View on ClinicalTrials.gov

Safety of BBB Opening With the SonoCloud

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

July 31, 2018

Study Completion Date

July 31, 2018

Conditions
GlioblastomaGliomaBrain Tumor
Interventions
DEVICE

SonoCloud

SonoCloud : dose escalation

DRUG

Carboplatin

Carboplatin : min 6 cycles - individual dose determination according to renal function and AUC

Trial Locations (1)

75013

Groupe Hospitalier Pitié Salpetriere - Neurosurgery Department, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT02253212 - Safety of BBB Opening With the SonoCloud | Biotech Hunter | Biotech Hunter